Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo
about
Inhibitory effects and underlying mechanism of 7-hydroxyflavone phosphate ester in HeLa cellsResistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicityProgesterone induces the growth and infiltration of human astrocytoma cells implanted in the cerebral cortex of the rat.Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression.Glucocorticoid regulation of SLIT/ROBO tumour suppressor genes in the ovarian surface epithelium and ovarian cancer cells.Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamicsAntiprogestins in gynecological diseases.Synthetic gestagens exert differential effects on arterial thrombosis and aortic gene expression in ovariectomized apolipoprotein E-deficient miceAntihormonal agents as a strategy to improve the effect of chemo-radiation in cervical cancer: in vitro and in vivo studyThe Role of Mifepristone in Meningiomas Management: A Systematic Review of the LiteratureGrowth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2.Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.Long-term primary culture of a clear cell ovarian carcinoma reveals an epithelial-mesenchymal cooperative interaction.Drug Repurposing for Cancer Therapy.Synergistic lethality of mifepristone and LY294002 in ovarian cancer cellsMifepristone Suppresses Basal Triple-Negative Breast Cancer Stem Cells by Down-regulating KLF5 Expression.Mifepristone improves chemo-radiation response in glioblastoma xenografts.The prince and the pauper. A tale of anticancer targeted agents.Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity.Sex differences in cell proliferation and glucocorticoid responsiveness in the zebra finch brainMifepristone abrogates repopulation of ovarian cancer cells in between courses of cisplatin treatmentComparison of power between randomized discontinuation design and upfront randomization design on progression-free survival.Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cellsThe unique pharmacological characteristics of mifepristone (RU486): from terminating pregnancy to preventing cancer metastasis.RU486 Induces Pro-Apoptotic Endoplasmic Reticulum Stress Through the Induction of CHOP Expression by Enhancing C/EBPδ Expression in Human Renal Carcinoma Caki Cells.GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors.
P2860
Q28483410-555D9AD7-CBF5-47DB-8C76-42F75C29411DQ33554192-C6F2E42F-47EA-4383-8677-03FACC360534Q33745937-AD597752-24BE-47AB-9A81-284E739CB374Q33914314-4FED585E-1BDC-4F18-A140-AFA2179DA7B7Q34087872-671ADF91-136A-4A46-9E40-9C1856B0F410Q34285363-3B5BDA81-A613-43F0-ADC2-9E1E76BE0C9CQ34564141-15144603-40F6-464F-8BDE-FC8AEE857AE3Q34587636-54DEB5E3-F27A-4F4A-B713-9E5E743B2BB9Q34619444-0EB75454-8C60-4F77-BAA6-FD157C447DF8Q35030216-1B65242F-3904-4BC2-A3C0-6564E9D989A5Q35683023-6BD134AD-6F12-4858-BFCF-AEB00CCE238BQ35947321-9E50FEF9-86B2-4E5B-B4FA-FE6E8BAEEF29Q36016635-FE2D7664-60C8-4798-9D3D-33D4A3115887Q36088162-92518F51-29E6-497B-84AD-2D44ECFE67BBQ36229392-EF90BA78-A84B-4BA4-B615-1BE6C2DF72AFQ36607965-CD556F6D-4F76-416E-BF85-CDD78C7DCB51Q36644338-196738E0-EED4-48A0-8078-209430D7572DQ36766681-71DD6584-3D09-4133-B42F-A1644E8084C5Q37042365-A96BDB4F-3095-4F56-90D5-DC9BE4077126Q37140728-2A33A087-E4A8-4A3C-ABFB-C55B63D3AE39Q37183813-51B742A7-50E2-4D40-8D90-2F6E4D0ADE2DQ37213050-2C7AA138-4395-4CAF-AEAD-6443C09DF19BQ37325089-1EFCB2E0-AEBC-4485-9B58-80C191F59677Q37580909-7BEDE0DE-EC66-4768-87A5-77323AA4A65CQ37680211-DA152A3B-6725-4C14-90E4-C7CE0B1346A2Q38192568-7121520C-4DB5-4730-B165-1B2F8E911D34Q38853084-B114D657-FBE0-4B52-A3A8-C340DD32D780Q39798790-706C1123-DDA3-44DF-AF64-AC134B637B62Q41914993-D384EEB8-9984-4C75-80CC-8E6F3C39F54D
P2860
Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo
@en
type
label
Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo
@en
prefLabel
Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo
@en
P2093
P2860
P1476
Mifepristone inhibits ovarian cancer cell growth in vitro and in vivo
@en
P2093
Alicia A Goyeneche
Carlos M Telleria
Rubén W Carón
P2860
P304
P356
10.1158/1078-0432.CCR-07-0164
P407
P577
2007-06-01T00:00:00Z